Symbol="KPTI"
AssetType="Common Stock"
Name="Karyopharm Therapeutics Inc"
Description="Karyopharm Therapeutics Inc., a pharmaceutical company, is dedicated to the discovery, development and commercialization of various drugs directed against nuclear export and related targets for the treatment of cancer and other diseases. The company is headquartered in Newton, Massachusetts."
CIK="1503802"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2 MERCER ROAD, NATICK, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="205218000"
EBITDA="-124581000"
PERatio="None"
PEGRatio="-0.15"
BookValue="-0.396"
DividendPerShare="0"
DividendYield="0"
EPS="-1.75"
RevenuePerShareTTM="1.63"
ProfitMargin="-1.067"
OperatingMarginTTM="-0.846"
ReturnOnAssetsTTM="-0.253"
ReturnOnEquityTTM="-8.91"
RevenueTTM="148102000"
GrossProfitTTM="151861000"
DilutedEPSTTM="-1.75"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.188"
AnalystTargetPrice="7.11"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.05"
PriceToBookRatio="12.05"
EVToRevenue="1.652"
EVToEBITDA="-6.85"
Beta="-0.0321"
num_52WeekHigh="6.01"
num_52WeekLow="1.44"
num_50DayMovingAverage="1.98"
num_200DayMovingAverage="3.351"
SharesOutstanding="114010000"
DividendDate="None"
ExDividendDate="None"
symbol="KPTI"
open="1.70"
high="1.80"
low="1.69"
price="1.80"
volume="3397532.00"
latest_trading_day="2023-07-28"
previous_close="1.69"
change="0.11"
change_percent="6.5089%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="64"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="36"
Volume_recent_avg="3113899"
Change_recent_avg="-0.01"
Delta_recent_avg="0.23"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.73"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="36"
Aroon_momentum_negative="64"
image_negative_thumbnail_id_1="154"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0022.jpeg"
image_negative_thumbnail_id_2="151"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0025.jpeg"
image_neutral_thumbnail_id_1="569"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_neutral_thumbnail_id_2="562"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_positive_thumbnail_id_1="632"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0076.jpeg"
image_positive_thumbnail_id_2="973"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0135.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
